Skip to main navigation Skip to search Skip to main content

New DNA Vaccines Study Findings Recently Were Reported by Researchers at Catholic University of Korea (Gx-188e Dna Vaccine Plus Pembrolizumab In Hpv 16-and/or 18-positive Recurrent or Advance Cervical Cancer: a Phase 2 Trial)

Press/Media

Period12 Aug 2024

Media coverage

1

Media coverage

  • TitleNew DNA Vaccines Study Findings Recently Were Reported by Researchers at Catholic University of Korea (Gx-188e Dna Vaccine Plus Pembrolizumab In Hpv 16-and/or 18-positive Recurrent or Advance Cervical Cancer: a Phase 2 Trial)
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date12/08/24
    PersonsSung-Hoon Kim